nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—epilepsy syndrome	0.246	1	CbGaD
Palonosetron—CYP1A2—Carbamazepine—epilepsy syndrome	0.0296	0.0662	CbGbCtD
Palonosetron—CYP1A2—Primidone—epilepsy syndrome	0.0277	0.0618	CbGbCtD
Palonosetron—CYP1A2—Propofol—epilepsy syndrome	0.0248	0.0554	CbGbCtD
Palonosetron—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0247	0.0552	CbGbCtD
Palonosetron—CYP1A2—Phenobarbital—epilepsy syndrome	0.0237	0.0529	CbGbCtD
Palonosetron—CYP3A4—Felbamate—epilepsy syndrome	0.023	0.0513	CbGbCtD
Palonosetron—CYP3A4—Trimethadione—epilepsy syndrome	0.023	0.0513	CbGbCtD
Palonosetron—CYP1A2—Diazepam—epilepsy syndrome	0.0225	0.0502	CbGbCtD
Palonosetron—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0216	0.0483	CbGbCtD
Palonosetron—CYP2D6—Propofol—epilepsy syndrome	0.0204	0.0456	CbGbCtD
Palonosetron—CYP3A4—Clonazepam—epilepsy syndrome	0.0195	0.0437	CbGbCtD
Palonosetron—CYP3A4—Clobazam—epilepsy syndrome	0.0187	0.0419	CbGbCtD
Palonosetron—CYP1A2—Valproic Acid—epilepsy syndrome	0.0177	0.0395	CbGbCtD
Palonosetron—CYP3A4—Rufinamide—epilepsy syndrome	0.0159	0.0356	CbGbCtD
Palonosetron—CYP3A4—Carbamazepine—epilepsy syndrome	0.0155	0.0347	CbGbCtD
Palonosetron—CYP3A4—Primidone—epilepsy syndrome	0.0145	0.0324	CbGbCtD
Palonosetron—CYP3A4—Phenytoin—epilepsy syndrome	0.0139	0.0311	CbGbCtD
Palonosetron—CYP3A4—Propofol—epilepsy syndrome	0.013	0.029	CbGbCtD
Palonosetron—CYP3A4—Phenobarbital—epilepsy syndrome	0.0124	0.0277	CbGbCtD
Palonosetron—CYP3A4—Acetazolamide—epilepsy syndrome	0.0124	0.0277	CbGbCtD
Palonosetron—CYP3A4—Midazolam—epilepsy syndrome	0.0122	0.0273	CbGbCtD
Palonosetron—CYP3A4—Diazepam—epilepsy syndrome	0.0118	0.0263	CbGbCtD
Palonosetron—CYP3A4—Zonisamide—epilepsy syndrome	0.0115	0.0257	CbGbCtD
Palonosetron—CYP3A4—Valproic Acid—epilepsy syndrome	0.00928	0.0207	CbGbCtD
Palonosetron—CYP3A4—Topiramate—epilepsy syndrome	0.00837	0.0187	CbGbCtD
Palonosetron—HTR3A—vagus nerve—epilepsy syndrome	0.00648	0.371	CbGeAlD
Palonosetron—HTR3A—ganglion—epilepsy syndrome	0.0025	0.143	CbGeAlD
Palonosetron—Praziquantel—CYP2C19—epilepsy syndrome	0.00179	0.574	CrCbGaD
Palonosetron—Praziquantel—CYP2D6—epilepsy syndrome	0.00133	0.426	CrCbGaD
Palonosetron—HTR3A—brainstem—epilepsy syndrome	0.00109	0.0622	CbGeAlD
Palonosetron—HTR3A—forebrain—epilepsy syndrome	0.00105	0.06	CbGeAlD
Palonosetron—HTR3A—telencephalon—epilepsy syndrome	0.000964	0.0552	CbGeAlD
Palonosetron—CYP2D6—hindbrain—epilepsy syndrome	0.000696	0.0399	CbGeAlD
Palonosetron—HTR3A—head—epilepsy syndrome	0.0006	0.0344	CbGeAlD
Palonosetron—HTR3A—nervous system—epilepsy syndrome	0.000569	0.0326	CbGeAlD
Palonosetron—HTR3A—central nervous system—epilepsy syndrome	0.000548	0.0314	CbGeAlD
Palonosetron—HTR3A—brain—epilepsy syndrome	0.000435	0.0249	CbGeAlD
Palonosetron—CYP2D6—brainstem—epilepsy syndrome	0.000399	0.0228	CbGeAlD
Palonosetron—CYP2D6—forebrain—epilepsy syndrome	0.000385	0.0221	CbGeAlD
Palonosetron—CYP2D6—telencephalon—epilepsy syndrome	0.000354	0.0203	CbGeAlD
Palonosetron—CYP2D6—head—epilepsy syndrome	0.000221	0.0126	CbGeAlD
Palonosetron—CYP3A4—nervous system—epilepsy syndrome	0.000213	0.0122	CbGeAlD
Palonosetron—CYP2D6—nervous system—epilepsy syndrome	0.000209	0.012	CbGeAlD
Palonosetron—CYP3A4—central nervous system—epilepsy syndrome	0.000205	0.0117	CbGeAlD
Palonosetron—CYP2D6—central nervous system—epilepsy syndrome	0.000201	0.0115	CbGeAlD
Palonosetron—CYP2D6—cerebellum—epilepsy syndrome	0.000197	0.0113	CbGeAlD
Palonosetron—CYP2D6—brain—epilepsy syndrome	0.00016	0.00915	CbGeAlD
Palonosetron—Bradycardia—Topiramate—epilepsy syndrome	8.76e-05	0.000366	CcSEcCtD
Palonosetron—Nausea—Propofol—epilepsy syndrome	8.75e-05	0.000366	CcSEcCtD
Palonosetron—Vomiting—Fosphenytoin—epilepsy syndrome	8.73e-05	0.000365	CcSEcCtD
Palonosetron—Diarrhoea—Felbamate—epilepsy syndrome	8.73e-05	0.000365	CcSEcCtD
Palonosetron—Body temperature increased—Lamotrigine—epilepsy syndrome	8.72e-05	0.000365	CcSEcCtD
Palonosetron—Abdominal pain—Lamotrigine—epilepsy syndrome	8.72e-05	0.000365	CcSEcCtD
Palonosetron—Dysgeusia—Gabapentin—epilepsy syndrome	8.72e-05	0.000365	CcSEcCtD
Palonosetron—Dizziness—Diazepam—epilepsy syndrome	8.72e-05	0.000365	CcSEcCtD
Palonosetron—Infection—Valproic Acid—epilepsy syndrome	8.71e-05	0.000364	CcSEcCtD
Palonosetron—Rash—Fosphenytoin—epilepsy syndrome	8.66e-05	0.000362	CcSEcCtD
Palonosetron—Dermatitis—Fosphenytoin—epilepsy syndrome	8.65e-05	0.000362	CcSEcCtD
Palonosetron—Asthenia—Clonazepam—epilepsy syndrome	8.64e-05	0.000361	CcSEcCtD
Palonosetron—Headache—Fosphenytoin—epilepsy syndrome	8.61e-05	0.00036	CcSEcCtD
Palonosetron—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.6e-05	0.00036	CcSEcCtD
Palonosetron—Asthenia—Phenytoin—epilepsy syndrome	8.58e-05	0.000359	CcSEcCtD
Palonosetron—Nausea—Midazolam—epilepsy syndrome	8.56e-05	0.000358	CcSEcCtD
Palonosetron—Tachycardia—Valproic Acid—epilepsy syndrome	8.55e-05	0.000358	CcSEcCtD
Palonosetron—Diarrhoea—Zonisamide—epilepsy syndrome	8.55e-05	0.000357	CcSEcCtD
Palonosetron—Asthenia—Oxcarbazepine—epilepsy syndrome	8.53e-05	0.000357	CcSEcCtD
Palonosetron—Pruritus—Clonazepam—epilepsy syndrome	8.52e-05	0.000356	CcSEcCtD
Palonosetron—Vomiting—Vigabatrin—epilepsy syndrome	8.51e-05	0.000356	CcSEcCtD
Palonosetron—Skin disorder—Valproic Acid—epilepsy syndrome	8.51e-05	0.000356	CcSEcCtD
Palonosetron—Urinary tract disorder—Topiramate—epilepsy syndrome	8.5e-05	0.000355	CcSEcCtD
Palonosetron—Pruritus—Phenytoin—epilepsy syndrome	8.46e-05	0.000354	CcSEcCtD
Palonosetron—Connective tissue disorder—Topiramate—epilepsy syndrome	8.46e-05	0.000354	CcSEcCtD
Palonosetron—Nausea—Levetiracetam—epilepsy syndrome	8.45e-05	0.000354	CcSEcCtD
Palonosetron—Rash—Vigabatrin—epilepsy syndrome	8.44e-05	0.000353	CcSEcCtD
Palonosetron—Dizziness—Felbamate—epilepsy syndrome	8.44e-05	0.000353	CcSEcCtD
Palonosetron—Dermatitis—Vigabatrin—epilepsy syndrome	8.44e-05	0.000353	CcSEcCtD
Palonosetron—Urethral disorder—Topiramate—epilepsy syndrome	8.43e-05	0.000353	CcSEcCtD
Palonosetron—Pruritus—Oxcarbazepine—epilepsy syndrome	8.41e-05	0.000352	CcSEcCtD
Palonosetron—Convulsion—Pregabalin—epilepsy syndrome	8.41e-05	0.000352	CcSEcCtD
Palonosetron—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.41e-05	0.000352	CcSEcCtD
Palonosetron—Headache—Vigabatrin—epilepsy syndrome	8.39e-05	0.000351	CcSEcCtD
Palonosetron—Hypertension—Pregabalin—epilepsy syndrome	8.38e-05	0.000351	CcSEcCtD
Palonosetron—Vomiting—Diazepam—epilepsy syndrome	8.38e-05	0.000351	CcSEcCtD
Palonosetron—Anorexia—Valproic Acid—epilepsy syndrome	8.35e-05	0.000349	CcSEcCtD
Palonosetron—Rash—Diazepam—epilepsy syndrome	8.31e-05	0.000348	CcSEcCtD
Palonosetron—Dermatitis—Diazepam—epilepsy syndrome	8.3e-05	0.000347	CcSEcCtD
Palonosetron—Arthralgia—Pregabalin—epilepsy syndrome	8.27e-05	0.000346	CcSEcCtD
Palonosetron—Myalgia—Pregabalin—epilepsy syndrome	8.27e-05	0.000346	CcSEcCtD
Palonosetron—Dizziness—Zonisamide—epilepsy syndrome	8.26e-05	0.000345	CcSEcCtD
Palonosetron—Headache—Diazepam—epilepsy syndrome	8.26e-05	0.000345	CcSEcCtD
Palonosetron—Anxiety—Pregabalin—epilepsy syndrome	8.24e-05	0.000345	CcSEcCtD
Palonosetron—Diarrhoea—Clonazepam—epilepsy syndrome	8.24e-05	0.000345	CcSEcCtD
Palonosetron—Anaemia—Gabapentin—epilepsy syndrome	8.23e-05	0.000344	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.21e-05	0.000343	CcSEcCtD
Palonosetron—Hypotension—Valproic Acid—epilepsy syndrome	8.19e-05	0.000343	CcSEcCtD
Palonosetron—Asthenia—Carbamazepine—epilepsy syndrome	8.19e-05	0.000343	CcSEcCtD
Palonosetron—Diarrhoea—Phenytoin—epilepsy syndrome	8.18e-05	0.000342	CcSEcCtD
Palonosetron—Discomfort—Pregabalin—epilepsy syndrome	8.17e-05	0.000342	CcSEcCtD
Palonosetron—Nausea—Fosphenytoin—epilepsy syndrome	8.16e-05	0.000341	CcSEcCtD
Palonosetron—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.14e-05	0.00034	CcSEcCtD
Palonosetron—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.13e-05	0.00034	CcSEcCtD
Palonosetron—Vomiting—Felbamate—epilepsy syndrome	8.11e-05	0.000339	CcSEcCtD
Palonosetron—Dry mouth—Pregabalin—epilepsy syndrome	8.08e-05	0.000338	CcSEcCtD
Palonosetron—Pruritus—Carbamazepine—epilepsy syndrome	8.07e-05	0.000338	CcSEcCtD
Palonosetron—Rash—Felbamate—epilepsy syndrome	8.05e-05	0.000337	CcSEcCtD
Palonosetron—Eye disorder—Topiramate—epilepsy syndrome	8.04e-05	0.000336	CcSEcCtD
Palonosetron—Dermatitis—Felbamate—epilepsy syndrome	8.04e-05	0.000336	CcSEcCtD
Palonosetron—Tinnitus—Topiramate—epilepsy syndrome	8.02e-05	0.000336	CcSEcCtD
Palonosetron—Headache—Felbamate—epilepsy syndrome	7.99e-05	0.000334	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.99e-05	0.000334	CcSEcCtD
Palonosetron—Cardiac disorder—Topiramate—epilepsy syndrome	7.99e-05	0.000334	CcSEcCtD
Palonosetron—Dizziness—Clonazepam—epilepsy syndrome	7.96e-05	0.000333	CcSEcCtD
Palonosetron—Nausea—Vigabatrin—epilepsy syndrome	7.95e-05	0.000333	CcSEcCtD
Palonosetron—Vomiting—Zonisamide—epilepsy syndrome	7.94e-05	0.000332	CcSEcCtD
Palonosetron—Insomnia—Valproic Acid—epilepsy syndrome	7.93e-05	0.000332	CcSEcCtD
Palonosetron—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.92e-05	0.000331	CcSEcCtD
Palonosetron—Asthenia—Lamotrigine—epilepsy syndrome	7.91e-05	0.000331	CcSEcCtD
Palonosetron—Dizziness—Phenytoin—epilepsy syndrome	7.91e-05	0.000331	CcSEcCtD
Palonosetron—Rash—Zonisamide—epilepsy syndrome	7.88e-05	0.000329	CcSEcCtD
Palonosetron—Infection—Pregabalin—epilepsy syndrome	7.87e-05	0.000329	CcSEcCtD
Palonosetron—Paraesthesia—Valproic Acid—epilepsy syndrome	7.87e-05	0.000329	CcSEcCtD
Palonosetron—Dermatitis—Zonisamide—epilepsy syndrome	7.87e-05	0.000329	CcSEcCtD
Palonosetron—Dizziness—Oxcarbazepine—epilepsy syndrome	7.86e-05	0.000329	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.86e-05	0.00169	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.84e-05	0.00168	CbGpPWpGaD
Palonosetron—Nausea—Diazepam—epilepsy syndrome	7.83e-05	0.000328	CcSEcCtD
Palonosetron—Headache—Zonisamide—epilepsy syndrome	7.82e-05	0.000327	CcSEcCtD
Palonosetron—Dyspnoea—Valproic Acid—epilepsy syndrome	7.81e-05	0.000327	CcSEcCtD
Palonosetron—Diarrhoea—Carbamazepine—epilepsy syndrome	7.81e-05	0.000327	CcSEcCtD
Palonosetron—Angiopathy—Topiramate—epilepsy syndrome	7.81e-05	0.000327	CcSEcCtD
Palonosetron—Pruritus—Lamotrigine—epilepsy syndrome	7.8e-05	0.000326	CcSEcCtD
Palonosetron—Shock—Pregabalin—epilepsy syndrome	7.8e-05	0.000326	CcSEcCtD
Palonosetron—Somnolence—Valproic Acid—epilepsy syndrome	7.79e-05	0.000326	CcSEcCtD
Palonosetron—Immune system disorder—Topiramate—epilepsy syndrome	7.77e-05	0.000325	CcSEcCtD
Palonosetron—Nervous system disorder—Pregabalin—epilepsy syndrome	7.77e-05	0.000325	CcSEcCtD
Palonosetron—Mediastinal disorder—Topiramate—epilepsy syndrome	7.75e-05	0.000324	CcSEcCtD
Palonosetron—Tachycardia—Pregabalin—epilepsy syndrome	7.73e-05	0.000324	CcSEcCtD
Palonosetron—Chills—Topiramate—epilepsy syndrome	7.72e-05	0.000323	CcSEcCtD
Palonosetron—Dyspepsia—Valproic Acid—epilepsy syndrome	7.72e-05	0.000323	CcSEcCtD
Palonosetron—Convulsion—Gabapentin—epilepsy syndrome	7.71e-05	0.000323	CcSEcCtD
Palonosetron—Skin disorder—Pregabalin—epilepsy syndrome	7.7e-05	0.000322	CcSEcCtD
Palonosetron—Hypertension—Gabapentin—epilepsy syndrome	7.69e-05	0.000322	CcSEcCtD
Palonosetron—Vomiting—Clonazepam—epilepsy syndrome	7.65e-05	0.00032	CcSEcCtD
Palonosetron—Decreased appetite—Valproic Acid—epilepsy syndrome	7.62e-05	0.000319	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	7.61e-05	0.00163	CbGpPWpGaD
Palonosetron—Alopecia—Topiramate—epilepsy syndrome	7.6e-05	0.000318	CcSEcCtD
Palonosetron—Vomiting—Phenytoin—epilepsy syndrome	7.6e-05	0.000318	CcSEcCtD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	7.6e-05	0.00163	CbGpPWpGaD
Palonosetron—Rash—Clonazepam—epilepsy syndrome	7.59e-05	0.000317	CcSEcCtD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	7.58e-05	0.00163	CbGpPWpGaD
Palonosetron—Dermatitis—Clonazepam—epilepsy syndrome	7.58e-05	0.000317	CcSEcCtD
Palonosetron—Myalgia—Gabapentin—epilepsy syndrome	7.58e-05	0.000317	CcSEcCtD
Palonosetron—Arthralgia—Gabapentin—epilepsy syndrome	7.58e-05	0.000317	CcSEcCtD
Palonosetron—Nausea—Felbamate—epilepsy syndrome	7.58e-05	0.000317	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.57e-05	0.000317	CcSEcCtD
Palonosetron—Vomiting—Oxcarbazepine—epilepsy syndrome	7.56e-05	0.000316	CcSEcCtD
Palonosetron—Fatigue—Valproic Acid—epilepsy syndrome	7.56e-05	0.000316	CcSEcCtD
Palonosetron—Anxiety—Gabapentin—epilepsy syndrome	7.55e-05	0.000316	CcSEcCtD
Palonosetron—Anorexia—Pregabalin—epilepsy syndrome	7.55e-05	0.000316	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	7.55e-05	0.00162	CbGpPWpGaD
Palonosetron—Dizziness—Carbamazepine—epilepsy syndrome	7.55e-05	0.000316	CcSEcCtD
Palonosetron—Diarrhoea—Lamotrigine—epilepsy syndrome	7.55e-05	0.000316	CcSEcCtD
Palonosetron—Headache—Clonazepam—epilepsy syndrome	7.54e-05	0.000315	CcSEcCtD
Palonosetron—Rash—Phenytoin—epilepsy syndrome	7.54e-05	0.000315	CcSEcCtD
Palonosetron—Mental disorder—Topiramate—epilepsy syndrome	7.54e-05	0.000315	CcSEcCtD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	7.53e-05	0.00162	CbGpPWpGaD
Palonosetron—Dermatitis—Phenytoin—epilepsy syndrome	7.53e-05	0.000315	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.53e-05	0.000315	CcSEcCtD
Palonosetron—Rash—Oxcarbazepine—epilepsy syndrome	7.5e-05	0.000314	CcSEcCtD
Palonosetron—Constipation—Valproic Acid—epilepsy syndrome	7.5e-05	0.000314	CcSEcCtD
Palonosetron—Pain—Valproic Acid—epilepsy syndrome	7.5e-05	0.000314	CcSEcCtD
Palonosetron—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.49e-05	0.000313	CcSEcCtD
Palonosetron—Headache—Phenytoin—epilepsy syndrome	7.49e-05	0.000313	CcSEcCtD
Palonosetron—Erythema—Topiramate—epilepsy syndrome	7.49e-05	0.000313	CcSEcCtD
Palonosetron—Malnutrition—Topiramate—epilepsy syndrome	7.49e-05	0.000313	CcSEcCtD
Palonosetron—Discomfort—Gabapentin—epilepsy syndrome	7.49e-05	0.000313	CcSEcCtD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	7.49e-05	0.00161	CbGpPWpGaD
Palonosetron—Headache—Oxcarbazepine—epilepsy syndrome	7.45e-05	0.000312	CcSEcCtD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	7.43e-05	0.0016	CbGpPWpGaD
Palonosetron—Nausea—Zonisamide—epilepsy syndrome	7.42e-05	0.00031	CcSEcCtD
Palonosetron—Dry mouth—Gabapentin—epilepsy syndrome	7.41e-05	0.00031	CcSEcCtD
Palonosetron—Hypotension—Pregabalin—epilepsy syndrome	7.4e-05	0.00031	CcSEcCtD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	7.39e-05	0.00159	CbGpPWpGaD
Palonosetron—Flatulence—Topiramate—epilepsy syndrome	7.38e-05	0.000309	CcSEcCtD
Palonosetron—Dysgeusia—Topiramate—epilepsy syndrome	7.34e-05	0.000307	CcSEcCtD
Palonosetron—Dizziness—Lamotrigine—epilepsy syndrome	7.29e-05	0.000305	CcSEcCtD
Palonosetron—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.27e-05	0.000304	CcSEcCtD
Palonosetron—Vomiting—Carbamazepine—epilepsy syndrome	7.26e-05	0.000304	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.22e-05	0.000302	CcSEcCtD
Palonosetron—Infection—Gabapentin—epilepsy syndrome	7.22e-05	0.000302	CcSEcCtD
Palonosetron—Rash—Carbamazepine—epilepsy syndrome	7.2e-05	0.000301	CcSEcCtD
Palonosetron—Dermatitis—Carbamazepine—epilepsy syndrome	7.19e-05	0.000301	CcSEcCtD
Palonosetron—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.17e-05	0.0003	CcSEcCtD
Palonosetron—Insomnia—Pregabalin—epilepsy syndrome	7.17e-05	0.0003	CcSEcCtD
Palonosetron—Nausea—Clonazepam—epilepsy syndrome	7.15e-05	0.000299	CcSEcCtD
Palonosetron—Headache—Carbamazepine—epilepsy syndrome	7.15e-05	0.000299	CcSEcCtD
Palonosetron—Shock—Gabapentin—epilepsy syndrome	7.15e-05	0.000299	CcSEcCtD
Palonosetron—Nervous system disorder—Gabapentin—epilepsy syndrome	7.13e-05	0.000298	CcSEcCtD
Palonosetron—Paraesthesia—Pregabalin—epilepsy syndrome	7.12e-05	0.000298	CcSEcCtD
Palonosetron—Nausea—Phenytoin—epilepsy syndrome	7.1e-05	0.000297	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.1e-05	0.00152	CbGpPWpGaD
Palonosetron—Tachycardia—Gabapentin—epilepsy syndrome	7.09e-05	0.000297	CcSEcCtD
Palonosetron—Dyspnoea—Pregabalin—epilepsy syndrome	7.06e-05	0.000296	CcSEcCtD
Palonosetron—Nausea—Oxcarbazepine—epilepsy syndrome	7.06e-05	0.000296	CcSEcCtD
Palonosetron—Skin disorder—Gabapentin—epilepsy syndrome	7.06e-05	0.000295	CcSEcCtD
Palonosetron—Somnolence—Pregabalin—epilepsy syndrome	7.04e-05	0.000295	CcSEcCtD
Palonosetron—Vomiting—Lamotrigine—epilepsy syndrome	7.01e-05	0.000293	CcSEcCtD
Palonosetron—Rash—Lamotrigine—epilepsy syndrome	6.95e-05	0.000291	CcSEcCtD
Palonosetron—Dermatitis—Lamotrigine—epilepsy syndrome	6.95e-05	0.000291	CcSEcCtD
Palonosetron—Abdominal pain—Valproic Acid—epilepsy syndrome	6.93e-05	0.00029	CcSEcCtD
Palonosetron—Body temperature increased—Valproic Acid—epilepsy syndrome	6.93e-05	0.00029	CcSEcCtD
Palonosetron—Anorexia—Gabapentin—epilepsy syndrome	6.93e-05	0.00029	CcSEcCtD
Palonosetron—Anaemia—Topiramate—epilepsy syndrome	6.92e-05	0.00029	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.92e-05	0.00149	CbGpPWpGaD
Palonosetron—Headache—Lamotrigine—epilepsy syndrome	6.91e-05	0.000289	CcSEcCtD
Palonosetron—Decreased appetite—Pregabalin—epilepsy syndrome	6.89e-05	0.000288	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.84e-05	0.000286	CcSEcCtD
Palonosetron—Fatigue—Pregabalin—epilepsy syndrome	6.83e-05	0.000286	CcSEcCtD
Palonosetron—Hypotension—Gabapentin—epilepsy syndrome	6.79e-05	0.000284	CcSEcCtD
Palonosetron—Nausea—Carbamazepine—epilepsy syndrome	6.78e-05	0.000284	CcSEcCtD
Palonosetron—Pain—Pregabalin—epilepsy syndrome	6.78e-05	0.000283	CcSEcCtD
Palonosetron—Constipation—Pregabalin—epilepsy syndrome	6.78e-05	0.000283	CcSEcCtD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	6.76e-05	0.00145	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	6.72e-05	0.00144	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	6.67e-05	0.00143	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.65e-05	0.00143	CbGpPWpGaD
Palonosetron—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.62e-05	0.000277	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.6e-05	0.00142	CbGpPWpGaD
Palonosetron—Insomnia—Gabapentin—epilepsy syndrome	6.57e-05	0.000275	CcSEcCtD
Palonosetron—Nausea—Lamotrigine—epilepsy syndrome	6.55e-05	0.000274	CcSEcCtD
Palonosetron—Paraesthesia—Gabapentin—epilepsy syndrome	6.52e-05	0.000273	CcSEcCtD
Palonosetron—Convulsion—Topiramate—epilepsy syndrome	6.49e-05	0.000271	CcSEcCtD
Palonosetron—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.48e-05	0.000271	CcSEcCtD
Palonosetron—Dyspnoea—Gabapentin—epilepsy syndrome	6.48e-05	0.000271	CcSEcCtD
Palonosetron—Hypertension—Topiramate—epilepsy syndrome	6.47e-05	0.000271	CcSEcCtD
Palonosetron—Somnolence—Gabapentin—epilepsy syndrome	6.46e-05	0.00027	CcSEcCtD
Palonosetron—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.46e-05	0.00027	CcSEcCtD
Palonosetron—Dyspepsia—Gabapentin—epilepsy syndrome	6.4e-05	0.000268	CcSEcCtD
Palonosetron—Myalgia—Topiramate—epilepsy syndrome	6.38e-05	0.000267	CcSEcCtD
Palonosetron—Arthralgia—Topiramate—epilepsy syndrome	6.38e-05	0.000267	CcSEcCtD
Palonosetron—Anxiety—Topiramate—epilepsy syndrome	6.35e-05	0.000266	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.33e-05	0.000265	CcSEcCtD
Palonosetron—Decreased appetite—Gabapentin—epilepsy syndrome	6.32e-05	0.000264	CcSEcCtD
Palonosetron—Discomfort—Topiramate—epilepsy syndrome	6.3e-05	0.000264	CcSEcCtD
Palonosetron—Asthenia—Valproic Acid—epilepsy syndrome	6.29e-05	0.000263	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.27e-05	0.000262	CcSEcCtD
Palonosetron—Fatigue—Gabapentin—epilepsy syndrome	6.26e-05	0.000262	CcSEcCtD
Palonosetron—Body temperature increased—Pregabalin—epilepsy syndrome	6.26e-05	0.000262	CcSEcCtD
Palonosetron—Abdominal pain—Pregabalin—epilepsy syndrome	6.26e-05	0.000262	CcSEcCtD
Palonosetron—Dry mouth—Topiramate—epilepsy syndrome	6.24e-05	0.000261	CcSEcCtD
Palonosetron—Constipation—Gabapentin—epilepsy syndrome	6.21e-05	0.00026	CcSEcCtD
Palonosetron—Pain—Gabapentin—epilepsy syndrome	6.21e-05	0.00026	CcSEcCtD
Palonosetron—Pruritus—Valproic Acid—epilepsy syndrome	6.2e-05	0.000259	CcSEcCtD
Palonosetron—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	6.13e-05	0.00132	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	6.11e-05	0.00131	CbGpPWpGaD
Palonosetron—Infection—Topiramate—epilepsy syndrome	6.07e-05	0.000254	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	6.07e-05	0.0013	CbGpPWpGaD
Palonosetron—Shock—Topiramate—epilepsy syndrome	6.01e-05	0.000252	CcSEcCtD
Palonosetron—Diarrhoea—Valproic Acid—epilepsy syndrome	6e-05	0.000251	CcSEcCtD
Palonosetron—Nervous system disorder—Topiramate—epilepsy syndrome	6e-05	0.000251	CcSEcCtD
Palonosetron—Tachycardia—Topiramate—epilepsy syndrome	5.97e-05	0.00025	CcSEcCtD
Palonosetron—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.94e-05	0.000249	CcSEcCtD
Palonosetron—Skin disorder—Topiramate—epilepsy syndrome	5.94e-05	0.000248	CcSEcCtD
Palonosetron—Hypersensitivity—Pregabalin—epilepsy syndrome	5.84e-05	0.000244	CcSEcCtD
Palonosetron—Anorexia—Topiramate—epilepsy syndrome	5.83e-05	0.000244	CcSEcCtD
Palonosetron—Dizziness—Valproic Acid—epilepsy syndrome	5.8e-05	0.000242	CcSEcCtD
Palonosetron—Abdominal pain—Gabapentin—epilepsy syndrome	5.74e-05	0.00024	CcSEcCtD
Palonosetron—Body temperature increased—Gabapentin—epilepsy syndrome	5.74e-05	0.00024	CcSEcCtD
Palonosetron—Hypotension—Topiramate—epilepsy syndrome	5.71e-05	0.000239	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.7e-05	0.00122	CbGpPWpGaD
Palonosetron—Asthenia—Pregabalin—epilepsy syndrome	5.69e-05	0.000238	CcSEcCtD
Palonosetron—Pruritus—Pregabalin—epilepsy syndrome	5.61e-05	0.000235	CcSEcCtD
Palonosetron—Vomiting—Valproic Acid—epilepsy syndrome	5.57e-05	0.000233	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.57e-05	0.000233	CcSEcCtD
Palonosetron—Insomnia—Topiramate—epilepsy syndrome	5.53e-05	0.000231	CcSEcCtD
Palonosetron—Rash—Valproic Acid—epilepsy syndrome	5.53e-05	0.000231	CcSEcCtD
Palonosetron—Dermatitis—Valproic Acid—epilepsy syndrome	5.52e-05	0.000231	CcSEcCtD
Palonosetron—Headache—Valproic Acid—epilepsy syndrome	5.49e-05	0.00023	CcSEcCtD
Palonosetron—Paraesthesia—Topiramate—epilepsy syndrome	5.49e-05	0.00023	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	5.48e-05	0.00118	CbGpPWpGaD
Palonosetron—Dyspnoea—Topiramate—epilepsy syndrome	5.45e-05	0.000228	CcSEcCtD
Palonosetron—Somnolence—Topiramate—epilepsy syndrome	5.43e-05	0.000227	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.43e-05	0.00117	CbGpPWpGaD
Palonosetron—Diarrhoea—Pregabalin—epilepsy syndrome	5.42e-05	0.000227	CcSEcCtD
Palonosetron—Dyspepsia—Topiramate—epilepsy syndrome	5.38e-05	0.000225	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.38e-05	0.00116	CbGpPWpGaD
Palonosetron—Hypersensitivity—Gabapentin—epilepsy syndrome	5.35e-05	0.000224	CcSEcCtD
Palonosetron—Decreased appetite—Topiramate—epilepsy syndrome	5.31e-05	0.000222	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.28e-05	0.000221	CcSEcCtD
Palonosetron—Fatigue—Topiramate—epilepsy syndrome	5.27e-05	0.00022	CcSEcCtD
Palonosetron—Dizziness—Pregabalin—epilepsy syndrome	5.24e-05	0.000219	CcSEcCtD
Palonosetron—Constipation—Topiramate—epilepsy syndrome	5.23e-05	0.000219	CcSEcCtD
Palonosetron—Pain—Topiramate—epilepsy syndrome	5.23e-05	0.000219	CcSEcCtD
Palonosetron—Asthenia—Gabapentin—epilepsy syndrome	5.21e-05	0.000218	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.21e-05	0.00112	CbGpPWpGaD
Palonosetron—Nausea—Valproic Acid—epilepsy syndrome	5.21e-05	0.000218	CcSEcCtD
Palonosetron—Pruritus—Gabapentin—epilepsy syndrome	5.14e-05	0.000215	CcSEcCtD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.06e-05	0.00109	CbGpPWpGaD
Palonosetron—Vomiting—Pregabalin—epilepsy syndrome	5.04e-05	0.000211	CcSEcCtD
Palonosetron—Gastrointestinal pain—Topiramate—epilepsy syndrome	5e-05	0.000209	CcSEcCtD
Palonosetron—Rash—Pregabalin—epilepsy syndrome	5e-05	0.000209	CcSEcCtD
Palonosetron—Dermatitis—Pregabalin—epilepsy syndrome	4.99e-05	0.000209	CcSEcCtD
Palonosetron—Diarrhoea—Gabapentin—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Palonosetron—Headache—Pregabalin—epilepsy syndrome	4.96e-05	0.000208	CcSEcCtD
Palonosetron—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	4.96e-05	0.00107	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	4.93e-05	0.00106	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.89e-05	0.00105	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	4.89e-05	0.00105	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	4.89e-05	0.00105	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.86e-05	0.00104	CbGpPWpGaD
Palonosetron—Body temperature increased—Topiramate—epilepsy syndrome	4.83e-05	0.000202	CcSEcCtD
Palonosetron—Abdominal pain—Topiramate—epilepsy syndrome	4.83e-05	0.000202	CcSEcCtD
Palonosetron—Dizziness—Gabapentin—epilepsy syndrome	4.8e-05	0.000201	CcSEcCtD
Palonosetron—Nausea—Pregabalin—epilepsy syndrome	4.71e-05	0.000197	CcSEcCtD
Palonosetron—Vomiting—Gabapentin—epilepsy syndrome	4.62e-05	0.000193	CcSEcCtD
Palonosetron—Rash—Gabapentin—epilepsy syndrome	4.58e-05	0.000192	CcSEcCtD
Palonosetron—Dermatitis—Gabapentin—epilepsy syndrome	4.58e-05	0.000191	CcSEcCtD
Palonosetron—Headache—Gabapentin—epilepsy syndrome	4.55e-05	0.00019	CcSEcCtD
Palonosetron—Hypersensitivity—Topiramate—epilepsy syndrome	4.5e-05	0.000188	CcSEcCtD
Palonosetron—Asthenia—Topiramate—epilepsy syndrome	4.39e-05	0.000183	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	4.36e-05	0.000935	CbGpPWpGaD
Palonosetron—Pruritus—Topiramate—epilepsy syndrome	4.33e-05	0.000181	CcSEcCtD
Palonosetron—Nausea—Gabapentin—epilepsy syndrome	4.32e-05	0.000181	CcSEcCtD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.29e-05	0.000921	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	4.23e-05	0.000909	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	4.2e-05	0.000903	CbGpPWpGaD
Palonosetron—Diarrhoea—Topiramate—epilepsy syndrome	4.18e-05	0.000175	CcSEcCtD
Palonosetron—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	4.18e-05	0.000897	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.15e-05	0.00089	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.12e-05	0.000885	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.1e-05	0.000881	CbGpPWpGaD
Palonosetron—Dizziness—Topiramate—epilepsy syndrome	4.04e-05	0.000169	CcSEcCtD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.96e-05	0.00085	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	3.94e-05	0.000845	CbGpPWpGaD
Palonosetron—Vomiting—Topiramate—epilepsy syndrome	3.89e-05	0.000163	CcSEcCtD
Palonosetron—Rash—Topiramate—epilepsy syndrome	3.85e-05	0.000161	CcSEcCtD
Palonosetron—Dermatitis—Topiramate—epilepsy syndrome	3.85e-05	0.000161	CcSEcCtD
Palonosetron—Headache—Topiramate—epilepsy syndrome	3.83e-05	0.00016	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	3.82e-05	0.000819	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	3.77e-05	0.000809	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.72e-05	0.000798	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.71e-05	0.000796	CbGpPWpGaD
Palonosetron—Nausea—Topiramate—epilepsy syndrome	3.63e-05	0.000152	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.48e-05	0.000747	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	3.42e-05	0.000735	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	3.42e-05	0.000735	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CA13—epilepsy syndrome	3.39e-05	0.000729	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.39e-05	0.000728	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	3.33e-05	0.000716	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.31e-05	0.000711	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.26e-05	0.000701	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.26e-05	0.0007	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.24e-05	0.000697	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.22e-05	0.000692	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.2e-05	0.000687	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.18e-05	0.000683	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.96e-05	0.000637	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.91e-05	0.000625	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CA13—epilepsy syndrome	2.88e-05	0.000617	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.87e-05	0.000616	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	2.86e-05	0.000613	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	2.86e-05	0.000613	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.68e-05	0.000576	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADK—epilepsy syndrome	2.57e-05	0.000552	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—FAR1—epilepsy syndrome	2.57e-05	0.000552	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	2.57e-05	0.000552	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	2.57e-05	0.000552	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CERS1—epilepsy syndrome	2.57e-05	0.000552	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PDXK—epilepsy syndrome	2.57e-05	0.000552	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	2.35e-05	0.000505	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GAMT—epilepsy syndrome	2.35e-05	0.000505	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	2.35e-05	0.000505	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PNPO—epilepsy syndrome	2.35e-05	0.000505	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.31e-05	0.000497	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.22e-05	0.000476	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CA4—epilepsy syndrome	2.19e-05	0.00047	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—QDPR—epilepsy syndrome	2.19e-05	0.00047	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PDXK—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—FAR1—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CERS1—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADK—epilepsy syndrome	2.18e-05	0.000468	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—COX3—epilepsy syndrome	2.06e-05	0.000442	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.99e-05	0.000428	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.99e-05	0.000428	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.99e-05	0.000428	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.99e-05	0.000428	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.95e-05	0.000419	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.95e-05	0.000419	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.95e-05	0.000419	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.95e-05	0.000419	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.95e-05	0.000419	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.85e-05	0.000398	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.85e-05	0.000398	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.85e-05	0.000397	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.78e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.78e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.78e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.74e-05	0.000374	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.72e-05	0.000369	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.68e-05	0.000361	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.68e-05	0.000361	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.68e-05	0.000361	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.68e-05	0.000361	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.68e-05	0.000361	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.68e-05	0.000361	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.66e-05	0.000356	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.66e-05	0.000356	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.65e-05	0.000355	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.65e-05	0.000355	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.65e-05	0.000355	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.65e-05	0.000355	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.65e-05	0.000355	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.61e-05	0.000347	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.6e-05	0.000344	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.56e-05	0.000335	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.54e-05	0.00033	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.54e-05	0.00033	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.54e-05	0.00033	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.54e-05	0.00033	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.52e-05	0.000326	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.51e-05	0.000324	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.51e-05	0.000324	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.51e-05	0.000324	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.48e-05	0.000317	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.48e-05	0.000317	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.45e-05	0.000312	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.43e-05	0.000307	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.43e-05	0.000307	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.43e-05	0.000306	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.41e-05	0.000303	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.41e-05	0.000303	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.4e-05	0.000302	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.4e-05	0.000302	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.38e-05	0.000296	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.37e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.35e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.34e-05	0.000289	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.33e-05	0.000285	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.32e-05	0.000283	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.3e-05	0.000279	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.28e-05	0.000276	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.27e-05	0.000274	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.27e-05	0.000274	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.27e-05	0.000274	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.27e-05	0.000274	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.27e-05	0.000274	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.25e-05	0.000269	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.25e-05	0.000269	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.22e-05	0.000261	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.19e-05	0.000256	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.19e-05	0.000256	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.18e-05	0.000254	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.17e-05	0.000251	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.17e-05	0.00025	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.17e-05	0.00025	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.17e-05	0.00025	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.14e-05	0.000246	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.12e-05	0.000241	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.12e-05	0.000241	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.1e-05	0.000237	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.08e-05	0.000233	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.08e-05	0.000233	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.07e-05	0.000229	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.07e-05	0.000229	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.03e-05	0.000221	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.02e-05	0.000219	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1e-05	0.000215	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	9.91e-06	0.000213	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NT5E—epilepsy syndrome	9.66e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALAD—epilepsy syndrome	9.66e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.61e-06	0.000206	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	9.22e-06	0.000198	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	9.22e-06	0.000198	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	9.05e-06	0.000194	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	9.05e-06	0.000194	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	9.02e-06	0.000194	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADSL—epilepsy syndrome	8.83e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	8.71e-06	0.000187	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GLUL—epilepsy syndrome	8.66e-06	0.000186	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	8.5e-06	0.000183	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	8.49e-06	0.000182	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	8.43e-06	0.000181	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.43e-06	0.000181	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.26e-06	0.000177	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.95e-06	0.000171	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AQP1—epilepsy syndrome	7.72e-06	0.000166	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	7.38e-06	0.000158	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	7.25e-06	0.000156	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BCHE—epilepsy syndrome	7.22e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	7.19e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	7.14e-06	0.000153	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.09e-06	0.000152	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.98e-06	0.00015	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.98e-06	0.00015	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	6.88e-06	0.000148	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	6.81e-06	0.000146	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TH—epilepsy syndrome	6.78e-06	0.000146	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.47e-06	0.000139	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	6.45e-06	0.000138	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	6.14e-06	0.000132	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BCHE—epilepsy syndrome	6.11e-06	0.000131	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	5.83e-06	0.000125	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	5.77e-06	0.000124	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TH—epilepsy syndrome	5.75e-06	0.000123	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.69e-06	0.000122	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.66e-06	0.000122	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.66e-06	0.000121	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.59e-06	0.00012	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.55e-06	0.000119	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.51e-06	0.000118	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.43e-06	0.000117	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.05e-06	0.000108	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.98e-06	0.000107	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	4.8e-06	0.000103	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.74e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAT—epilepsy syndrome	4.73e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.72e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	4.6e-06	9.88e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.5e-06	9.66e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.45e-06	9.56e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TH—epilepsy syndrome	4.44e-06	9.52e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.43e-06	9.51e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.34e-06	9.32e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX1—epilepsy syndrome	4.28e-06	9.19e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.75e-06	8.06e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.73e-06	8.01e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.7e-06	7.95e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOE—epilepsy syndrome	3.68e-06	7.89e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.65e-06	7.84e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.55e-06	7.63e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.4e-06	7.3e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.3e-06	7.09e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.16e-06	6.78e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.97e-06	6.39e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.9e-06	6.22e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.88e-06	6.18e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.84e-06	6.09e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.52e-06	5.41e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.44e-06	5.23e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.22e-06	4.77e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.94e-06	4.17e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.49e-06	3.21e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.27e-06	2.72e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.77e-07	2.1e-05	CbGpPWpGaD
